Skip to main content
2024 CRT Conference Main banner
Back

Innovation

Renal Denervation and Hypertension Therapies [Non-CME]

Renal Denervation and Hypertension Therapies [Non-CME]

Sunday, March 10, 2024
1:30 PM – 5:45 PM ET

    Program Director(s)

  • David Kandzari, MD, FACC, FSCAI

    Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
    Piedmont Heart Institute
    Atlanta, Georgia, United States

  • Felix Mahfoud, MD

    Professor
    Saarland University Hospital
    Homburg/Saar, Saarland, Germany

  • Vasilios Papademetriou, MD, DSc

    Director Interventional Hypertension and Vascular Medicine
    Georgetown University/VAMC
    Washington, District of Columbia, United States

  • Andrew Sharp, MD

    Consultant Cardiologist
    University Hospital of Wales
    Cardiff, United Kingdom

Presentations:

  • 1:30 PM – 1:38 PM ET
    Science and Myths Behind Device-Based Technology

    Speaker: Aloke V. Finn, MD – CVPath

  • 1:30 PM – 3:40 PM ET
    RENAL DENERVATION TREATMENT FOR UNCONTROLLED HYPERTENSION: INNOVATIVE TECHNOLOGY UPDATE

    Moderator: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

    Moderator: Vasilios Papademetriou, MD, DSc – Georgetown University/VAMC

  • 1:38 PM – 1:46 PM ET
    The Unmet Need for Renal Denervation

    Speaker: Vasilios Papademetriou, MD, DSc – Georgetown University/VAMC

  • 1:46 PM – 1:54 PM ET
    From Clinical Trials to Clinical Practice | Symplicity Spyral RDN System

    Speaker: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute

  • 1:54 PM – 2:32 PM ET
    Case-in-a-Box | RECOR Paradise Ultrasound RDN System

    Case Presenter: Aravinda Nanjundappa, MD, FSCAI – Cleveland Clinic , Main Campus

    Panel Moderator: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute

    Panel Moderator: Felix Mahfoud, MD – Saarland University Hospital

    Panel Discussant: Herbert D. Aronow, MD, MPH – Henry Ford Health

    Panel Discussant: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona

    Panel Discussant: Michael Weber, MD – SUNY Downstate Medical College

  • 2:32 PM – 2:40 PM ET
    From Clinical Trials to Clinical Practice: RECOR Paradise Technology

    Speaker: Andrew SP Sharp, MD – University Hospital of Wales

  • 2:40 PM – 2:48 PM ET
    Who Should I Refer for Renal Denervation Therapy and Why?

    Speaker: Michael Weber, MD – SUNY Downstate Medical College

  • 2:48 PM – 2:56 PM ET
    Current Status of Renal Denervation in Europe | Who is Getting the RDN Therapy?

    Speaker: Felix Mahfoud, MD – Saarland University Hospital

  • 2:56 PM – 3:04 PM ET
    Renal Denervation, Drugs, or Both for the Management of Hypertension?

    Speaker: Vasilios Papademetriou, MD, DSc – Georgetown University/VAMC

  • 3:04 PM – 3:12 PM ET
    Reimbursement: Expectations and Reality for Approved Renal Denervation Systems

    Speaker: William S. Weintraub, MD – MedStar Washington Hospital Center

  • 3:12 PM – 3:40 PM ET
    Case-in-a-Box | Medtronic Symplicity Spyral Renal Denervation System

    Case Presenter: Brian Fulton, MD – Penn Medicine

    Panel Moderator: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

    Panel Moderator: Vasilios Papademetriou, MD, DSc – Georgetown University/VAMC

    Panel Discussant: Herbert D. Aronow, MD, MPH – Henry Ford Health

    Panel Discussant: Aloke V. Finn, MD – CVPath

    Panel Discussant: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute

    Panel Discussant: Michael S. Lee, MD, FACC, FSCAI – Southern California Hospital

    Panel Discussant: Felix Mahfoud, MD – Saarland University Hospital

    Panel Discussant: Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center

  • 3:40 PM – 3:48 PM ET
    BackBeat AVIM Therapy

    Speaker: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

  • 3:40 PM – 5:45 PM ET
    RENAL DENERVATION | TECHNOLOGIES SESSION

    Moderator: Herbert D. Aronow, MD, MPH – Henry Ford Health

    Moderator: Justin E. Davies, MD, PhD – Imperial College London

    Moderator: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona

    Moderator: Timir Paul, MD, PhD, FACC, FSCAI – University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital

  • 3:48 PM – 3:56 PM ET
    Chemical Renal Denervation with Ethanol Clinical Trial Update

    Speaker: Felix Mahfoud, MD – Saarland University Hospital

  • 3:56 PM – 4:04 PM ET
    Role of LAA Ligation in Neuro Hormonal Modulation and Hypertension

    Speaker: Dhanunjaya Lakkireddy, MD – Kansas City Heart Rhythm Institute and Research Foundation

  • 4:04 PM – 4:12 PM ET
    How to Perform a Safe and Effective Radiofrequency RDN

    Speaker: Herbert D. Aronow, MD, MPH – Henry Ford Health

  • 4:12 PM – 4:20 PM ET
    Pivotal Trial of Renal Mapping/Selective RDN To Treat Hypertension: Results at 6 Months

    Speaker: Jie Wang, MD, PhD – Jiangsu Province Hospital

  • 4:20 PM – 4:28 PM ET
    How Do I Manage Uncontrolled Hypertension Today with Pharmacology and Beyond? What Are the New Options?

    Speaker: Michael Weber, MD – SUNY Downstate Medical College

  • 4:28 PM – 4:36 PM ET
    How to Mitigate Gender and Racial Disparities for Essential Hypertension

    Speaker: Ileana L. Pina, MD, MPH – Thomas Jefferson University

  • 4:36 PM – 4:44 PM ET
    Six Differentiating Features of the Non-Vascular Approach to Renal Denervation: One-Year Follow-Up

    Speaker: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona

  • 4:44 PM – 4:52 PM ET
    How to Perform Pulmonary Denervation for PAH

    Speaker: Shaoliang Chen, MD – Nanjing First Hospital,Nanjing Medical University

  • 4:52 PM – 5:00 PM ET
    What Is the Potential Role for RDN in Treating Atrial Fibrillation and CHF?

    Speaker: Tim A. Fischell, MD, FACC – Ascension Borgess Heart Institute

  • 5:00 PM – 5:08 PM ET
    Debate: My Patient Has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for Renal Denervation

    Speaker: Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center

  • 5:08 PM – 5:16 PM ET
    Debate: My Patient Has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for Pharmacology Escalation

    Speaker: Judith Veis, MD – Medstar Washington Hospital Center

  • 5:16 PM – 5:24 PM ET
    Patient Selection for RDN | What's Important?

    Speaker: Felix Mahfoud, MD – Saarland University Hospital

  • 5:24 PM – 5:32 PM ET
    Dietary and Pharmacologic Approaches to Hypertension Management in 2024 – What’s New and What’s Changed

    Speaker: Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC – University of Louisville

  • 5:32 PM – 5:45 PM ET
    Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation

    Panel Moderator: Vasilios Papademetriou, MD, DSc – Georgetown University/VAMC

    Panel Moderator: Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center

    Panel Moderator: Michael Weber, MD – SUNY Downstate Medical College

    Panel Discussant: Justin E. Davies, MD, PhD – Imperial College London

    Panel Discussant: Tim A. Fischell, MD, FACC – Ascension Borgess Heart Institute

    Panel Discussant: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona

    Panel Discussant: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute

    Panel Discussant: Felix Mahfoud, MD – Saarland University Hospital

    Panel Discussant: John P. Reilly, MD – Stony Brook Southampton Hospital

    Panel Discussant: Judith Veis, MD – Medstar Washington Hospital Center

    Panel Discussant: Jie Wang, MD, PhD – Jiangsu Province Hospital

    Panel Discussant: William S. Weintraub, MD – MedStar Washington Hospital Center

  • 5:45 PM ET
    Adjourn